Related Experiment Video
Updated: May 30, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
How to minimize low enrolling sites: a case study in diabetes
Abby Abraham1, Janet Jones, Sunitha Vikram
1Associate Director, Clinical Operations ICON Clinical Research, India.
Perspectives in Clinical Research
|August 11, 2011
Summary
Indian clinical trial sites show higher patient recruitment rates than the global average. This study identifies key attributes of high-performing sites to enhance overall subject recruitment strategies for global clinical trials in India.
Area of Science:
- Clinical research
- Pharmacoeconomics
- Health services research
Background:
- India is emerging as a significant global hub for clinical trial conduct.
- Indian clinical trial sites demonstrate a higher subject recruitment rate compared to the global average.
- There is a need to optimize recruitment performance by analyzing site-specific factors.
Purpose of the Study:
- To identify attributes associated with high-performing Indian clinical trial sites.
- To develop strategies for improving patient recruitment processes in India.
- To provide actionable insights for Clinical Research Associates (CRAs) to enhance site performance.
Main Methods:
- Case study analysis comparing high and low performing Indian clinical trial sites.
- Utilizing clinical trial data and insights to identify performance drivers.
- Developing a framework for site selection and patient recruitment enhancement.
Main Results:
- Indian sites generally exhibit superior subject recruitment rates.
- Key attributes influencing performance include PI/study team availability and interest, historical study data, and competitor analysis.
- A proactive approach by CRAs, including site-specific recruitment plans and strong CRA-Investigator relationships, is crucial.
Conclusions:
- Analyzing site performance trends can differentiate high and low recruiting sites.
- Effective CRA support, including proactive issue resolution and motivational strategies, is vital for meeting recruitment targets.
- Optimizing the CRA-Investigator relationship is critical for achieving high recruitment performance in Indian clinical trials.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...